Fhma Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 24 Days
- Last Filing with ROC 31 Mar 2018
About Fhma Biotech
Fhma Biotech Private Limited (FBPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 January 2018 (Seven years 24 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashwinder Panasar, Makki Ibrahim, and Gurbir Singh serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2018PTC304149
-
Company No.
304149
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Jan 2018
-
Date of AGM
30 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Fhma Biotech Private Limited offer?
Fhma Biotech Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products.
Who are the key members and board of directors at Fhma Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwinder Panasar
|
Director | 15-Jan-2018 | Current |
Makki Ibrahim
|
Director | 16-Jan-2018 | Current |
|
Gurbir Singh
|
Director | 15-Jan-2018 | Current |
Financial Performance of Fhma Biotech.
Enhance accessibility to Fhma Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fhma Biotech?
Unlock access to Fhma Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Innoethica Impacto Private LimitedAshwinder Panasar is a mutual person
-
Gsmpa Arts (Opc) Private Limited
Ashwinder Panasar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fhma Biotech?
Unlock and access historical data on people associated with Fhma Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fhma Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fhma Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.